Fagan Associates’s State Street Health Care Select Sector SPDR ETF XLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-14,651
Closed -$1.97M 139
2025
Q2
$1.97M Sell
14,651
-701
-5% -$94.7K 0.31% 65
2025
Q1
$2.24M Sell
15,352
-887
-5% -$129K 0.37% 64
2024
Q4
$2.23M Buy
16,239
+218
+1% +$31.9K 0.35% 66
2024
Q3
$2.47M Sell
16,021
-247
-2% -$37.4K 0.41% 63
2024
Q2
$2.37M Sell
16,268
-212
-1% -$30.4K 0.41% 62
2024
Q1
$2.43M Sell
16,480
-108
-0.7% -$15.5K 0.46% 59
2023
Q4
$2.26M Sell
16,588
-559
-3% -$72.7K 0.49% 53
2023
Q3
$2.21M Buy
17,147
+46
+0.3% +$6.11K 0.53% 48
2023
Q2
$2.27M Sell
17,101
-105
-0.6% -$13.8K 0.55% 46
2023
Q1
$2.23M Buy
17,206
+1,779
+12% +$232K 0.55% 48
2022
Q4
$2.1M Buy
15,427
+1,258
+9% +$167K 0.56% 48
2022
Q3
$1.72M Buy
14,169
+284
+2% +$36.6K 0.48% 48
2022
Q2
$1.78M Buy
13,885
+7,453
+116% +$977K 0.48% 48
2022
Q1
$881K Sell
6,432
-163
-2% -$21.6K 0.18% 79
2021
Q4
$929K Buy
6,595
+373
+6% +$49.5K 0.18% 78
2021
Q3
$792K Buy
6,222
+801
+15% +$106K 0.17% 83
2021
Q2
$683K Buy
5,421
+1,137
+27% +$139K 0.15% 91
2021
Q1
$500K Sell
4,284
-5
-0.1% -$577 0.12% 94
2020
Q4
$486K Buy
4,289
+12
+0.3% +$1.31K 0.12% 88
2020
Q3
$451K Sell
4,277
-67
-2% -$7.05K 0.13% 84
2020
Q2
$435K Buy
4,344
+13
+0.3% +$1.28K 0.14% 83
2020
Q1
$384K Buy
4,331
+189
+5% +$18.4K 0.15% 81
2019
Q4
$422K Sell
4,142
-210
-5% -$20.2K 0.14% 92
2019
Q3
$392K Buy
4,352
+148
+4% +$13.5K 0.15% 90
2019
Q2
$389K Sell
4,204
-96
-2% -$8.63K 0.16% 94
2019
Q1
$395K Buy
4,300
+12
+0.3% +$1.08K 0.17% 94
2018
Q4
$371K Buy
4,288
+15
+0.4% +$1.36K 0.19% 91
2018
Q3
$407K Sell
4,273
-87
-2% -$7.86K 0.17% 99
2018
Q2
$364K Sell
4,360
-107
-2% -$8.87K 0.16% 96
2018
Q1
$364 Sell
4,467
-18
-0.4% -$1.53K 0.16% 87
2017
Q4
$371 Buy
4,485
+44
+1% +$3.63K 0.15% 91
2017
Q3
$363K Buy
4,441
+12
+0.3% +$964 0.18% 91
2017
Q2
$351K Buy
4,429
+13
+0.3% +$990 0.18% 91
2017
Q1
$328K Sell
4,416
-174
-4% -$12.7K 0.18% 88
2016
Q4
$316K Buy
4,590
+15
+0.3% +$1.04K 0.18% 91
2016
Q3
$330K Sell
4,575
-36
-0.8% -$2.65K 0.2% 84
2016
Q2
$331K Buy
4,611
+14
+0.3% +$986 0.21% 79
2016
Q1
$312K Sell
4,597
-63
-1% -$4.22K 0.21% 79
2015
Q4
$336K Buy
4,660
+34
+0.7% +$2.4K 0.22% 77
2015
Q3
$306K Buy
4,626
+14
+0.3% +$1.02K 0.22% 79
2015
Q2
$343K Buy
4,612
+12
+0.3% +$889 0.23% 79
2015
Q1
$333K Sell
4,600
-40
-0.9% -$2.85K 0.25% 78
2014
Q4
$317K Buy
4,640
+63
+1% +$4.22K 0.25% 76
2014
Q3
$293K Buy
4,577
+25
+0.5% +$1.57K 0.24% 78
2014
Q2
$177K Buy
4,552
+12
+0.3% +$705 0.15% 83
2014
Q1
$266K Buy
+4,540
New +$262K 0.23% 77

Other funds holding XLV

Fagan Associates's XLV Position: Q3 2025 in Review

Fagan Associates sold out of State Street Health Care Select Sector SPDR ETF (XLV) in Q3 2025, closing a stake of 14,651 shares — an estimated $1.97M sold.

Fagan Associates first reported a position in XLV in Q1 2014 and held it in 46 quarters. The position peaked at $2.47M in Q3 2024. 1,647 funds tracked by Wall St. Rank hold XLV as of Q3 2025.

  • Fagan Associates reported no remaining State Street Health Care Select Sector SPDR ETF position as of Q3 2025 after selling out during the quarter.
  • Fagan Associates sold 14,651 State Street Health Care Select Sector SPDR ETF shares in Q3 2025, an estimated $1.97M.
  • Fagan Associates first reported a position in State Street Health Care Select Sector SPDR ETF in Q1 2014 and held it in 46 quarters.
  • Fagan Associates's State Street Health Care Select Sector SPDR ETF position peaked at $2.47M in Q3 2024.
  • 1,647 funds tracked by Wall St. Rank held State Street Health Care Select Sector SPDR ETF as of Q3 2025.

Based on Fagan Associates's 13F filing for Q3 2025, filed 14 Nov 2025.